Search Results 231-240 of 15111 for TNF

  1. Safety and Feasibility of Kefir Administration in Critically Ill Adults - Mayo Clinic

    Premorbid known immunosuppression over 1 month duration (due to medications including chronic steroids, TNF-alpha inhibitors, monoclonal antibodies, ...

  2. CardiolRx In Recurrent Pericarditis Following IL-1 Blocker Cessation - Mayo Clinic

    Canakinumab, TNF inhibitors, IL-6 inhibitors, or janus-activating kinase inhibitors (within 12 weeks) 4. Intravenous immune globulin (IVIG) (within 8 weeks)

  3. A Study to Evaluate the Effectiveness and Safety of Glepaglutide in the Treatment of Short Bowel Syndrome - Mayo Clinic

    Unstable biological therapy (e.g., anti-TNF-α, natalizumab, etc.) within 6 months prior to Screening, including significant changes in doses or switch of ...

  4. Publications - Michael C. Stephens, M.D. - Mayo Clinic

    2023 Jun 23; 21(1):410. View PubMed; Reinhart JP, Aird JL, Stephens MC, Asch S, Orandi AB, Tollefson MM. Tumor necrosis factor-alpha inhibitor-induced ...

  5. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    ... tumor necrosis factor [anti-TNF] agents) ≤ 2 weeks prior to registration. Note: Patients who have received acute, low dose, systemic immunosuppressant ...

  6. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  7. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  9. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  10. Study Of GS-1427 In Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ... TNF-α inhibitors, counts as 1 mechanism of action) Key Exclusion Criteria: * Have a current diagnosis of Crohn's Disease (CD) or clinical findings ...